On June 19, an amendment to Israel’s Economic Competition Law was approved. This amendment adds provisions prohibiting direct importers from harming parallel imports and personal imports. It also enables the imposition of...more
The Competition Director General has issued a precedent-setting determination against the pharmaceutical marketing company MBI Pharma Ltd. (MBI). The Director General determined that MBI abused its monopolistic position and...more
1/23/2023
/ Anti-Competitive ,
Competition Authorities ,
Corporate Fines ,
Drug Pricing ,
Enforcement Actions ,
Excessive Pricing ,
Israel ,
Ministry of Health ,
Monopolization ,
Pharmaceutical Industry ,
Prescription Drugs ,
Unfair Competition
On July 26, 2022, the Israeli Supreme Court handed down a precedent-setting ruling in the Central Bottle Company (Coca-Cola Israel) case (Permission for Civil Appeal Gafniel v. Central Bottle Company Ltd.). The court...more